Introduction
============

Spondylitis tuberculosis is an infectious disease of the spine caused by *Mycobacterium tuberculosis (M. tuberculosis)*. Spondylitis tuberculosis causes a defect of the corpus that can lead to spinal instability and disturbance of surrounding tissue. Healing of the bacterial infection is determined by the severity of corpus defect and the degree of bacterial infection in the spine \[[@B1]\]. The mainstay therapy of is surgery. However, results can be unsatisfactory with no spinal fusion evident. As an alternative treatment, we explored the documented potential of bone marrow stromal cells (BMSCs) in restoring the structural abnormalities in spondylitis tuberculosis cases \[[@B2][@B3][@B4][@B5][@B6][@B7][@B8]\].

Ossification is a part of bone formation that is influenced by cellular differentiation, osteocyte activity, and calcium deposit \[[@B6]\]. *M. tuberculosis* does not influence the differentiation of BMSCs into osteoblasts and ultimately to osteocytes *in vitro*, and decrease calcium deposition within the defect \[[@B7][@B8]\]. In the present study, we evaluated ossification in spondylitis tuberculosis affected bone by quantifying osteoblasts, osteocytes, and the calcium level of infected bone. The purpose of this research is to evaluate the interaction between *M. tuberculosis* and bone ossification *in vivo* using a rabbit model of spondylitis tuberculosis \[[@B6][@B7]\].

Materials and Methods
=====================

1. Approval
-----------

This research was an interventional research using an animal model. The research protocol was been reviewed and approved by the Animal Care and Use Committee (ACUC) PT Bimana Indomedical (No. R.02-12-IR), Komisi Pengawasan dan Kesejahteraan Penggunaan Hewan Percobaan IPB Animal Hospital (No. 02-21012), and the Research Ethical Committee of the Medical Research Unit (FMUIRSCM No. 521/PT02.FK/ETIK/2012). The majority of the research was conducted at these locales.

2. Rabbit model
---------------

Rabbits were inoculated directly with *M. tuberculosis* within the vertebral body (corpus) as described elsewhere \[[@B9][@B10][@B11][@B12][@B13]\]. Of the 14 rabbits inoculated, the intervention group and control group each comprised three rabbits. All steps were done on general anaesthesia using ketamin 44 mg/kg. Each rabbit was positioned facing laterally with the left back facing the operator. Identification of the 12th thoracic vertebrae was done by palpating the 12th rib then tracing it to the transverse process. An incision was made transversally to the T12 vertebrae starting from the spinous process 3--5 cm towards the left lateral penetrating skin and subcutaneous tissue. Paraspinal muscles were dissected until the 12th rib, transverse process, and 12th thoracal lamina. The bone was identified to determine the 12th thoracic body before a hole was drilled in the mid-point of the body ±5 mm from transverse process for 6 to 10 mm using a 1.5-mm drill bit. In the intervention group, up to 0.2 mL of a *M. tuberculosis* suspension containing 1×10^8^ viable bacteria per mL was inoculated aseptically into the hole made in the corpus. After a 5 min exposure to the open air the hole was closed by suturing the fascia, muscles, and subcutaneous tissue. In the control group, rabbits were inoculated with 0.2 mL of a NaCl solution. Surgical wounds were closed layer-by-layer and the skin was sutured one-by-one using 3.0 vycril and then closed by bandage. Rabbits were returned to their cage and observed until they recovered from anaesthesia. Isotonic NaCl was infused subcutaneously and 3 mg/kg ketoprofen was given for first 3 days post-inoculation. Rabbits were then held individually in cages for 8 weeks. Examinations during that time included acid fast bacilli staining, culture, polymerase chain reaction (PCR), and histopathology. The intervention group of rabbits were positive for culture, PCR, and histopathology. The control group of rabbits were positive for PCR and histopathology. Both groups received debridement, anti-tuberculosis regimen \[[@B1]\], scaffold placement of hydroxyapatite, and BMSC transplantation into the defective corpus. BMSC transplantation was done in conjunction with the debridement, defect creation, and implant fixation procedure. Defects were filled with 150 mg hydroxyapatite scaffold and transplanted with 6×10^6^ BMSCs. During the incubation period, each rabbit was examined clinically. After 6 weeks of follow-up, each rabbot was euthanized and the degree of ossification was assessed. The parameters measured objectively were osteoblast count, osteocyte count, and calcium level. Osteoblasts and osteocytes were microscopically enumerated in hematoxylin and eosin (H&E) stained specimens by two evaluators. The results from each rabbit in a group were combined to determine the mean value. Calcium level was determined using atomic emission spectroscopy.

Results
=======

Microscopy evaluation of H&E stained specimens at 400 times magnification ([Fig. 1](#F1){ref-type="fig"}) determined the mean±standard deviation osteoblast count as 207.00±31.00 in the intervention group and 220.33±73.46 cells in the control group. The respective osteocyte count was 18.33±30.04 and 31±26.87. The respective mean calcium level was 2.94%±0.98% and 2.51%±0.13%. All rabbits in the intervention group displayed good ossification based on the Ossification score ([Table 1](#T1){ref-type="table"}). Results in the control group were varied, with delayed, normal, and good ossification evident in one rabbit each ([Table 2](#T2){ref-type="table"}).

Discussion
==========

This study used a rabbit spondylitis tuberculosis model created by injection of 20×10^6^ cfu/mL *M. tuberculosis*, which was sufficient to cause infection. Rabbits with demonstrated infection were included in this study. All rabbits were treated with appropriate antibiotics in an effort to quell the infections. The six rabbits with persisting infections were used for the study. The oral anti-tuberculous drugs that were given aimed to prevent systemic infection, which could be fatal, and to reduce the number of viable *M. tuberculosis* colonies in the lesion and systemic circulation. The treatment was synchronized with the use of oral anti-tuberculous drugs given 2 weeks before surgery, except in emergency cases.

We evaluated specimens obtained at the time of surgery and euthanasia. The cultured specimens obtained after surgery were used to distinguish the two groups of rabbits. The euthanized specimens were used for purposes unrelated to the present study.

Diagnosis was determined by histopathologic examination, reflecting the specificity, accuracy, and rapid performance time of the approach. Acid fast bacilli test, culture, and PCR were also performed to determine the choice of treatment. Debridement of the infected lesion was done while creating an artificial defect to measure the volume defect. To achieve solid intervertebral fusion, 1.6×10^6^ BMSCs and hydroxyapatite scaffold was transplanted. BMSCs were provided because the large and inflamed defect could disturb new bone formation, considering the anti-inflammatory activity of the cells. The rational was the use of BMSCs to dampen inflammation and other immune responses to help kill *M. tuberculosis*.

During new bone formation, ossification continued in rabbits with ongoing *M. tuberculosis* infection and in the absence of infection, and even without debris after debridement. Administration of BMSCs at the site of bone defect in the presence of *M. tuberculosis* infection resulted in cell differentiation and subsequent ossification. The numbers of osteoblasts and osteocytes were similar to the numbers evident in rabbits without infection. But, infection was associated with disrupted bone matrix formation, as evident by the reduced osteocyte to osteoblast ratio compared to the ratio in uninfected rabbits and greater calcium deposition in infected rabbits.

The observations support the view *M. tuberculosis* infection increases the mobilization of calcium towards lesion for ossification. In this environment, the rate of bone cell metabolism could also increase, resulting in more bone mass formation. Fewer osteocytes are trapped in this environment, hence the bone mass that forms is relatively osteocyte-poor contains.

The ossification score was used to evaluate the ossification process in the manufactured defects. This score is a novel approach based on the osteoblast count, osteocyte count and bone calcium level. Each of the three parameters were rated as as negative (scored as 1), normal (scored as 5), or positive (scored as 15), and added together to determine the overall score ([Table 3](#T3){ref-type="table"}). A score \<18, 18--30, and \>30 indicated delayed ossification, normal ossification, and good ossification, respectively.

The three rabbits in the intervention group displayed an ossification score exceeding 30. In other words, ossification in infected rabbits was good ([Table 4](#T4){ref-type="table"}). Of In the three uninfected rabbits, two scored \<31 with the remaining rabbit scoring \<17, indicative of delayed bone formation. The results suggest that spondylitis tuberculosis promotes ossification. This may be because of the enhanced inflammation. Pro-inflammatory molecules including interleukin- 1 and -17, and tumor necrosis factor-alpha boost ossification \[[@B14][@B15]\].

Conclusions
===========

Spondylitis tuberculosis due to *M. tuberculosis* infection supports enhances ossification and new bone formation by stimulating calcium metabolism in lesions.
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![Evaluation of hemotoxylin and eosin-stained sagital section of defect tissue by microscopy at 400 times magnification. **(A)** Application of BMSCs in rabbit with spondylitis tuberculosis reveals inflammatory cells around the scaffold (green arrows). Osteoblast rimming (dark blue arrow) can be seen around the bony island (yellow arrow) as well as several osteocytes indicating good ossification (dark blue arrow). **(B)** A preparation from a rabbit that did not receive BMSCs. Few osteoblasts are evident (green arrow), with no osteocytes present. BMSCs, bone marrow stromal cells.](asj-10-1-g001){#F1}

###### Osteoblast, osteocyte count and calcium level of bone defect in both groups
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SD, standard deviation; NA, not applicable.

###### Ossification score of each subject
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Total score, 18 (delayed); 18--30 (normal); \>30 (good).

###### Ossification scoring determination
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###### Simulasion of ossification score
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Total score, 18 (delayed); 18--30 (normal); \> 30 (good).
